A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients
Status:
Withdrawn
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The main aim of this clinical study is to investigate whether the blood concentration of
methotrexate changes when AZD9056 is co- administered together with methotrexate.